St. Jude Medical LLC-医療機器分野:企業M&A・提携分析

◆英語タイトル:St. Jude Medical LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011121
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:99
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
St. Jude Medical LLC (SJM), a part of Abbott Laboratories, is a medical device company. It develops and manufactures devices for the cardiac rhythm management, cardiovascular, cardiac surgery and atrial fibrillation therapy areas, and implantable neurostimulation devices for the management of chronic pain. Its major products includes tachycardia implantable cardioverter defibrillator (ICD) systems; atrial fibrillation (AF) products; bradycardia pacemaker systems; vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring devices, heart valve replacement and repair products, structural heart defect devices, spinal cord stimulation and radiofrequency ablation products, ventricular assist devices and percutaneous heart pumps. The company along with its subsidiaries offers its products in the US, Europe and Asia Pacific. SJM is headquartered in St. Paul, Minnesota, the US.

St. Jude Medical LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
St. Jude Medical LLC, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
St. Jude Medical LLC, Medical Equipment Deals By Type, 2011 to YTD 2017 8
St. Jude Medical LLC, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
St. Jude Medical LLC, Medical Equipment, Deals By Market, 2011 to YTD 2017 10
St. Jude Medical LLC, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
St. Jude Medical LLC, Medical Equipment, Deal Details 14
Asset Purchase 14
Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For US$56.5 Million 14
Thoratec Acquires Medical Business Of Levitronix 16
NeuroTherm Acquires Parallax And Contour Product Lines From ArthroCare 17
Venture Financing 18
Apica Cardiovascular Secures USD1.48 Million in Venture Funding 18
Spinal Modulation Raises US$40 Million In Venture Financing 19
Nanostim Raises US$9.5 Million In Series C Financing 20
Spinal Modulation Raises US$2 Million In Venture Financing 21
Nanostim Raises US$10 Million In Venture Financing 22
Nanostim Raises US$10 Million In Venture Financing 23
Spinal Modulation Secures US$30 Million In Series D Financing 24
iRhythm Technologies Secures US$15 Million In Series C Venture Financing Round 26
Nanostim Raises US$5 Million In Venture Debt Financing 27
Nanostim Raises US$12.5 Million In Venture Equity Financing 28
Nanostim Raises US$1 Million In Venture Financing Round 29
APICA Cardiovascular Secures US$5 Million In Venture Financing Round 30
Private Equity 31
Linsalata Capital Partners Acquires NeuroTherm 31
Partnerships 32
APICA Cardiovascular Enters Into Licensing Agreement With Georgia Institute And Emory University 32
St. Jude Medical Enters Into Distribution Agreement With Spinal Modulation For Axium Neurostimulator System 33
Abbott Vascular Enters Into Co-Marketing Agreement With St. Jude Medical 34
Nihon Kohden Enters Into Distribution Agreement With St. Jude Medical For CRM Devices 35
St. Jude Medical Enters Into Technology Integration Agreement With Philips Healthcare 36
Siemens Enters Into Technology Integration Agreement With St. Jude Medical 37
Thoratec Enters Into Co-Development Agreement With WiTricity 38
Debt Offering 39
St. Jude Medical Completes Public Offering Of Notes Due 2043 For US$700 Million 39
St. Jude Medical Completes Public Offering Of Notes Due 2023 For US$900 Million 41
Asset Transactions 43
Terumo Acquires Portion of Vascular Closure Portfolio and Other Assets from St. Jude Medical and Abbott Labs for USD1.12 Billion 43
Vascular Solutions Acquires Venture Catheter From St. Jude Medical For US$3 Million 45
Acquisition 46
Abbott Labs Acquires St. Jude Medical for up to USD23.6 Billion 46
St. Jude Medical Acquires Thoratec for USD3.3 Billion 48
St. Jude Medical Acquires Spinal Modulation 50
Jude Medical Completes Acquisition of NeuroTherm for USD200 Million 51
Thoratec Acquires Apica Cardiovascular for up to USD75 Million 52
St. Jude Medical Completes Acquisition of Remaining 81% Stake in CardioMEMS for USD450 Million 53
St. Jude Medical Completes Acquisition Of Nanostim For US$123.5 Million 55
St. Jude Medical Acquires Endosense, Developer Of Cardiovascular Devices 57
St. Jude Medical LLC – Key Competitors 59
St. Jude Medical LLC – Key Employees 60
St. Jude Medical LLC – Locations And Subsidiaries 61
Head Office 61
Other Locations & Subsidiaries 61
Business Unit 64
Recent Developments 65
Financial Announcements 65
Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 65
Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 67
Apr 20, 2016: St. Jude Medical Reports First Quarter 2016 Results 69
Jan 27, 2016: St. Jude Medical Reports Fourth Quarter and Full-Year 2015 Results 71
Jan 13, 2016: St. Jude Medical Announces Preliminary Fourth Quarter 2015 Financial Results 73
Legal and Regulatory 75
Sep 07, 2016: St. Jude Medical Brings Legal Action Against Muddy Waters and MedSec 75
Product News 76
Jan 09, 2017: St. Jude Medical Announces Cybersecurity Updates 76
Oct 24, 2016: St. Jude Medical Announces Data to be Presented as Late-Breaking Clinical Trials and Highlights Its Latest Cardiovascular Portfolio at the 2016 TCT Conference 77
Oct 24, 2016: St. Jude Medical Recalls Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators Due to Premature Battery Depletion 78
Jul 14, 2016: ‘Healthy Tech’ on Display at Advocate Sherman Hospital 79
Jun 23, 2016: St. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies 80
May 19, 2016: New Data Presented at EuroPCR 2016 Adds to the Growing Body of Clinical Evidence Supporting St. Jude Medical FFR Technology and LAA Closure 82
03/10/2016: St. Jude Medical Secures CE Mark Approval of MRI Compatibility for the Nanostim Leadless Pacemaker 83
02/18/2016: FDA Panel Provides Leadership and Guidance to Companies Seeking to Advance Leadless Pacing Technology in the U.S. 84
02/17/2016: St. Jude Medical Announces FDA Approval Of A New Treatment Therapy For Patients Suffering From Chronic Intractable Pain 85
Feb 17, 2016: St. Jude Medical Receives FDA Approval for Industry’s First MultiPoint Pacing Technology 86
02/17/2016: St. Jude Medical Receives FDA Approval for Industry’s First MultiPoint Pacing Technology 87
02/08/2016: St. Jude Medical Announces Launch of OPTIS Mobile System in Europe and Japan 88
01/22/2016: FDA Classifies St. Jude Medical Field Action for 447 of the Company’s Optisure High Voltage Leads as a Class 1 Advisory in the U.S. 90
Product Approvals 91
Mar 10, 2016: St. Jude Medical Secures CE Mark Approval of MRI Compatibility for the Nanostim Leadless Pacemaker 91
Feb 17, 2016: St. Jude Medical Receives FDA Approval for Industry’s First MultiPoint Pacing Technology 92
Feb 17, 2016: St. Jude Medical Announces FDA Approval Of A New Treatment Therapy For Patients Suffering From Chronic Intractable Pain 93
Other Significant Developments 94
Oct 17, 2016: St. Jude Medical Announces it is Forming a Cyber Security Medical Advisory Board 94
Oct 11, 2016: St. Jude Medical – Important Medical Device Advisory 95
Aug 30, 2016: St. Jude Medical Continues to Refute Allegations made by Muddy Waters Capital and MedSec 96
Aug 26, 2016: St. Jude Medical Refutes Muddy Waters Device Security Allegations and Reinforces Security of Devices and Commitment to Patient Safety 97
Appendix 99
Methodology 99
About GlobalData 99
Contact Us 99
Disclaimer 99

List of Tables
St. Jude Medical LLC, Medical Equipment, Key Facts, 2016 2
St. Jude Medical LLC, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
St. Jude Medical LLC, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
St. Jude Medical LLC, Medical Equipment Deals By Type, 2011 to YTD 2017 8
St. Jude Medical LLC, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
St. Jude Medical LLC, Deals By Market, 2011 to YTD 2017 10
St. Jude Medical LLC, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For US$56.5 Million 14
Thoratec Acquires Medical Business Of Levitronix 16
NeuroTherm Acquires Parallax And Contour Product Lines From ArthroCare 17
Apica Cardiovascular Secures USD1.48 Million in Venture Funding 18
Spinal Modulation Raises US$40 Million In Venture Financing 19
Nanostim Raises US$9.5 Million In Series C Financing 20
Spinal Modulation Raises US$2 Million In Venture Financing 21
Nanostim Raises US$10 Million In Venture Financing 22
Nanostim Raises US$10 Million In Venture Financing 23
Spinal Modulation Secures US$30 Million In Series D Financing 24
iRhythm Technologies Secures US$15 Million In Series C Venture Financing Round 26
Nanostim Raises US$5 Million In Venture Debt Financing 27
Nanostim Raises US$12.5 Million In Venture Equity Financing 28
Nanostim Raises US$1 Million In Venture Financing Round 29
APICA Cardiovascular Secures US$5 Million In Venture Financing Round 30
Linsalata Capital Partners Acquires NeuroTherm 31
APICA Cardiovascular Enters Into Licensing Agreement With Georgia Institute And Emory University 32
St. Jude Medical Enters Into Distribution Agreement With Spinal Modulation For Axium Neurostimulator System 33
Abbott Vascular Enters Into Co-Marketing Agreement With St. Jude Medical 34
Nihon Kohden Enters Into Distribution Agreement With St. Jude Medical For CRM Devices 35
St. Jude Medical Enters Into Technology Integration Agreement With Philips Healthcare 36
Siemens Enters Into Technology Integration Agreement With St. Jude Medical 37
Thoratec Enters Into Co-Development Agreement With WiTricity 38
St. Jude Medical Completes Public Offering Of Notes Due 2043 For US$700 Million 39
St. Jude Medical Completes Public Offering Of Notes Due 2023 For US$900 Million 41
Terumo Acquires Portion of Vascular Closure Portfolio and Other Assets from St. Jude Medical and Abbott Labs for USD1.12 Billion 43
Vascular Solutions Acquires Venture Catheter From St. Jude Medical For US$3 Million 45
Abbott Labs Acquires St. Jude Medical for up to USD23.6 Billion 46
St. Jude Medical Acquires Thoratec for USD3.3 Billion 48
St. Jude Medical Acquires Spinal Modulation 50
Jude Medical Completes Acquisition of NeuroTherm for USD200 Million 51
Thoratec Acquires Apica Cardiovascular for up to USD75 Million 52
St. Jude Medical Completes Acquisition of Remaining 81% Stake in CardioMEMS for USD450 Million 53
St. Jude Medical Completes Acquisition Of Nanostim For US$123.5 Million 55
St. Jude Medical Acquires Endosense, Developer Of Cardiovascular Devices 57
St. Jude Medical LLC, Key Competitors 59
St. Jude Medical LLC, Key Employees 60
St. Jude Medical LLC, Other Locations 61
St. Jude Medical LLC, Subsidiaries 62
St. Jude Medical LLC, Business Unit 64

★海外企業調査レポート[St. Jude Medical LLC-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PACCAR Inc.:企業の戦略・SWOT・財務情報
    PACCAR Inc. - Strategy, SWOT and Corporate Finance Report Summary PACCAR Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Berg LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Berg LLC (Berg) is a biopharmaceutical company that focus on therapeutic discovery using AI-based Interrogative biology platform. The company’s proprietary platform Interrogative Biology, combines patient biology and artificial intelligence-based analytics to understand predictive patterns o …
  • Mount Gibson Iron Ltd:企業の戦略・SWOT・財務情報
    Mount Gibson Iron Ltd - Strategy, SWOT and Corporate Finance Report Summary Mount Gibson Iron Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AcuFocus Inc:医療機器:M&Aディール及び事業提携情報
    Summary AcuFocus Inc (AcuFocus) is an ophthalmic medical device company that develops and markets technologies for the improvement of near vision. The company develops and markets breakthrough technologies for the improvement of vision. It’s IC-8 IOL, a small aperture lens that is designed for preby …
  • Heron Therapeutics Inc (HRTX)-医療機器分野:企業M&A・提携分析
    Summary Heron Therapeutics Inc (Heron), formerly A.P. Pharma, Inc., is a biotechnology company that uses its proprietary polymer-based drug delivery platform to develop novel, patient-focused therapeutic products for patients suffering from cancer and pain. Its proprietary Biochronomer technology is …
  • GridEdge Networks Inc:企業の戦略的SWOT分析
    GridEdge Networks Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Cimarex Energy Co.:企業の戦略・SWOT・財務分析
    Cimarex Energy Co. - Strategy, SWOT and Corporate Finance Report Summary Cimarex Energy Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Jounce Therapeutics Inc (JNCE):製薬・医療:M&Aディール及び事業提携情報
    Summary Jounce Therapeutics Inc (Jounce) is a clinical stage immunotherapy company that develops therapies that enable the immune system to attack tumors. The company provides JTX-2011, an anti-ICOS monoclonal antibody which stimulates T effector cells to enhance anti-tumor activity; JTX-4014, an an …
  • Cosmo Oil Co Ltd:企業の戦略的SWOT分析
    Cosmo Oil Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • DBV Technologies SA (DBV):企業の財務・戦略的SWOT分析
    Summary DBV Technologies SA (DBV) is a biopharmaceutical company that develops products for the diagnosis and treatment of food and pediatric allergies. The company develops and markets non-invasive epicutaneous delivery technology and products for healthcare markets. Its viaskin technology platform …
  • Excision BioTherapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Excision BioTherapeutics Inc (Excision BioTherapeutics) is a developer of gene editing therapeutics for the treatment of infectious diseases. The company’s products comprise EBT101, a HIV CRISPR Cas9 gRNA multiplex biologic for the prevention of Human Immunodeficiency Virus; EBT103, a PML JC …
  • Cardinal Ethanol LLC:企業の戦略的SWOT分析
    Cardinal Ethanol LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Northern Sun Mining Corp:企業の戦略・SWOT・財務分析
    Northern Sun Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Northern Sun Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Bharat Petroleum Corporation Limited:企業の戦略・SWOT・財務情報
    Bharat Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Transgene SA (TNG):企業の財務・戦略的SWOT分析
    Summary Transgene SA (Transgene) a subsidiary of Institut Merieux SA operates as a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company offers products such as therapeutic vaccines and oncolytic viruses. It develop …
  • Unchained Labs:製薬・医療:M&Aディール及び事業提携情報
    Summary Unchained Labs (Unchained) is a life science tools company which offers protein stability assessment products for biologics. Its product portfolio includes UNcle (biologics stability platform), HUNK (aggregation predictor), pUNk (protein sizing system), GRUNT (automated formulation preparati …
  • Laboratory Corp of America Holdings (LH):医療機器:M&Aディール及び事業提携情報
    Summary Laboratory Corp of America Holdings (LabCorp) is a provider of clinical laboratory services and end-to-end drug development support. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics la …
  • Millennium Minerals Limited:企業の戦略・SWOT・財務情報
    Millennium Minerals Limited - Strategy, SWOT and Corporate Finance Report Summary Millennium Minerals Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Mitsubishi Chemical Holdings Corporation:企業の戦略・SWOT・財務情報
    Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Arthur J. Gallagher & Co:企業の戦略・SWOT・財務情報
    Arthur J. Gallagher & Co - Strategy, SWOT and Corporate Finance Report Summary Arthur J. Gallagher & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆